Sweden has become the first country in the world to reach "smoke-free" status, with daily smoking rates falling below 5% of the adult population—the threshold the World Health Organization uses to define a smoke-free society. The milestone, confirmed by official health statistics released Monday, represents a decades-long public health effort that has relied heavily on controversial harm reduction strategies, particularly the widespread use of snus, a smokeless tobacco product.
According to data from the Swedish Public Health Agency, just 4.5% of adults now smoke daily, down from 15% two decades ago and dramatically lower than the European Union average of approximately 23%. The decline has been accompanied by equally dramatic improvements in smoking-related health outcomes, with Sweden posting the lowest rates of lung cancer and cardiovascular disease in Europe.
"This is an incredible public health achievement," said Dr. Lars Ramström, a researcher at the Institute for Tobacco Studies in Stockholm, in an interview with The Local. "Sweden has proven that it's possible to essentially eliminate smoking within a generation."
The path to smoke-free status has been unconventional and remains controversial within international public health circles. While most countries have pursued smoking reduction through taxation, advertising bans, and smoking cessation programs focused on complete nicotine abstinence, Sweden has taken a different approach: facilitating a shift from cigarettes to snus, a moist tobacco product placed under the upper lip.
Snus delivers nicotine but, because it is not combusted, does not produce the tar and toxic gases that make cigarette smoking so deadly. While it is not risk-free—studies link it to modest increases in pancreatic cancer and gum disease—the health impacts are substantially lower than those from smoking. An estimated 20% of Swedish adults now use snus regularly, with particularly high rates among men who might otherwise have been cigarette smokers.
To understand today's headlines, we must look at yesterday's decisions. Sweden's embrace of harm reduction stands in marked contrast to the approach taken by much of the international tobacco control community, which has historically insisted on abstinence-only policies and viewed alternative nicotine products with suspicion. The European Union actually banned the sale of snus in all member states except Sweden in 1992, a prohibition that remains in effect.
Critics of Sweden's approach argue that normalizing any tobacco product, even a less harmful one, perpetuates nicotine addiction and potentially serves as a gateway to smoking for young people. Dr. Vera Luiza da Costa e Silva, former head of the WHO's Tobacco Free Initiative, told the WHO that "the goal should be a tobacco-free society, not merely a smoke-free one."
However, Swedish data does not support the gateway hypothesis. Youth smoking rates have declined in tandem with adult rates, and surveys show that the vast majority of snus users are former smokers or people who would have otherwise smoked, not individuals who would have remained tobacco-free.
The success has prompted renewed debate about harm reduction strategies in tobacco control. Some public health experts now argue that Sweden's experience should inform policy in other countries struggling with high smoking rates. The United Kingdom has moved toward a harm reduction framework, particularly regarding vaping products, and has seen accelerating declines in smoking as a result.
Others remain skeptical. Dr. Margaret Chan, former WHO Director-General, has consistently warned that tobacco industry promotion of alternative products represents an attempt to maintain nicotine addiction and profits rather than a genuine public health strategy. The concern is that without strong regulation, harm reduction could become harm prolongation.
In Sweden, the regulatory approach has been characterized by pragmatism. Snus is heavily taxed, though not as heavily as cigarettes. Advertising is restricted. Products must meet manufacturing standards. Minors cannot purchase it. The government has not promoted snus use but has not actively discouraged the shift from cigarettes to snus either—a stance public health officials describe as "tolerance with regulation."
The economic implications of becoming smoke-free extend beyond health outcomes. Sweden spends significantly less on treating smoking-related diseases than comparable European countries, freeing healthcare resources for other priorities. Reduced smoking has also translated to fewer sick days and higher productivity, though quantifying these effects precisely is challenging.
Monday's announcement generated immediate international attention. Public health officials from countries with high smoking rates, including France, Poland, and Greece, face questions about whether Sweden's approach could be replicated. However, significant barriers exist, including entrenched tobacco industries, different cultural relationships with smoking, and—in the case of EU members—the continuing ban on snus sales.
As Stockholm celebrated its smoke-free milestone Monday, the achievement represented not just the culmination of decades of public health work but also a continuing challenge to global orthodoxies about tobacco control. Whether Sweden's path becomes a model for others or remains an outlier depends not just on evidence but on the willingness of governments and international organizations to embrace harm reduction strategies that prioritize health outcomes over ideological purity. The debate, like the issue of nicotine itself, is unlikely to be resolved quickly.
